DEAL EXTENDED ON LEVEL 1 AND LEVEL 2 COURSES

Saturday

190316

Role of Dietary Fructose and Hepatic De Novo Lipogenesis In Fatty Liver Disease

"Nonalcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome. Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened beverages are major risk factors for development of NAFLD. Today the most commonly consumed sugar is high fructose corn syrup. Hepatic lipids may be derived from dietary intake, esterification of plasma free fatty acids (FFA) or hepatic de novo lipogenesis (DNL). A central abnormality in NAFLD is enhanced DNL. ... In summary, fructose metabolism supports DNL more strongly than HFD and hepatic DNL is a central abnormality in NAFLD. Disrupting fructose metabolism in the liver may provide a new therapeutic option for the treatment of NAFLD."

Read MoreRole of Dietary Fructose and Hepatic De Novo Lipogenesis In Fatty Liver Disease